Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.

Literature DB >> 24550600

Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.

Mehmet A N Sendur¹, Sercan Aksoy², Nuriye Yıldırım Özdemir¹, Nurullah Zengin¹.

Abstract

Bevacizumab is a recombinant humanized monoclonal antibody that selectively blocks the activity of vascular endothelial growth factor (VEGF) receptor and it is used in metastatic colorectal patients. We present here a case of fatal necrotizing fasciitis in a patient during bevacizumab treatment for colorectal cancer. In our review of the literature, necrotizing fasciitis was not reported before or during bevacizumab treatment.

Entities: Chemical Disease Species

Keywords: Adverse drug reactions; bevacizumab; colorectal cancer; necrotizing fasciitis

Mesh：

Substances：

Year: 2014 PMID： 24550600 PMCID： PMC3912798 DOI： 10.4103/0253-7613.125195

Source DB: PubMed Journal: Indian J Pharmacol ISSN： 0253-7613 Impact factor: 1.200

10 in total

1. Necrotizing fasciitis.

Authors: Virendra N Sehgal; Naresh Sehgal; Ruchi Sehgal; Sujay Khandpur; Sonal Sharma
Journal: J Dermatolog Treat Date: 2006 Impact factor: 3.359

Review 2. Necrotizing fasciitis: current concepts and review of the literature.

Authors: Babak Sarani; Michelle Strong; Jose Pascual; C William Schwab
Journal: J Am Coll Surg Date: 2008-12-12 Impact factor: 6.113

Review 3. Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.

Authors: D Hompes; T Ruers
Journal: Eur J Surg Oncol Date: 2011-07-20 Impact factor: 4.424

4. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.

Authors: Fairooz F Kabbinavar; Julie Hambleton; Robert D Mass; Herbert I Hurwitz; Emily Bergsland; Somnath Sarkar
Journal: J Clin Oncol Date: 2005-05-02 Impact factor: 44.544

5. Necrotizing fasciitis in a renal transplant recipient treated with FK 506: the first reported case.

Authors: S Tang; T K Kwok; P L Ho; W M Tang; T M Chan; K N Lai
Journal: Clin Nephrol Date: 2001-12 Impact factor: 0.975

6. Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.

Authors: Dhave Setabutr; Nathan W Hales; Greg A Krempl
Journal: Am J Otolaryngol Date: 2009-03-26 Impact factor: 1.808

7. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.

Authors: Rosalyn E O'Loughlin; Angela Roberson; Paul R Cieslak; Ruth Lynfield; Ken Gershman; Allen Craig; Bernadette A Albanese; Monica M Farley; Nancy L Barrett; Nancy L Spina; Bernard Beall; Lee H Harrison; Arthur Reingold; Chris Van Beneden
Journal: Clin Infect Dis Date: 2007-08-29 Impact factor: 9.079

8. Fournier's gangrene and scrotal ulcerations during all-trans-retinoic acid therapy for acute promyelocytic leukemia.

Authors: Rahul Naithani; Rajat Kumar; M Mahapatra
Journal: Pediatr Blood Cancer Date: 2008-08 Impact factor: 3.167

9. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors: Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal: N Engl J Med Date: 2004-06-03 Impact factor: 91.245

10. Necrotizing fasciitis in irradiated tissue from diabetic women. A report of two cases.

Authors: C H Livengood; J T Soper; D L Clarke-Pearson; W A Addison
Journal: J Reprod Med Date: 1991-06 Impact factor: 0.142